Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery
Language English Country Czech Republic Media print
Document type Historical Article, Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
20131930
DOI
10.33549/physiolres.931918
PII: 931918
Knihovny.cz E-resources
- MeSH
- Biocompatible Materials MeSH
- Bioprosthesis * history trends MeSH
- Time Factors MeSH
- Blood Vessel Prosthesis * history trends MeSH
- Blood Vessel Prosthesis Implantation adverse effects history instrumentation trends MeSH
- History, 20th Century MeSH
- History, 21st Century MeSH
- Humans MeSH
- Vascular Diseases physiopathology surgery MeSH
- Graft Occlusion, Vascular etiology prevention & control MeSH
- Prosthesis Design MeSH
- Vascular Patency MeSH
- Tissue Engineering * history trends MeSH
- Treatment Outcome MeSH
- Animals MeSH
- Check Tag
- History, 20th Century MeSH
- History, 21st Century MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Historical Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Biocompatible Materials MeSH
The gold standard material in bypass surgery of blood vessels remains the patient's own artery or vein. However, this material may be unavailable, or may suffer vein graft disease. Currently available vascular prostheses, namely polyethylene terephthalate (PET, Dacron) and expanded polytetrafluoroethylene (ePTFE), perform well as large-caliber replacements, but their long-term patency is discouraging in small-caliber applications (<6 mm), such as in coronary, crural or microvessel surgery. This failure is mainly a result of an unfavorable healing process with surface thrombogenicity, due to lack of endothelial cells and anastomotic intimal hyperplasia caused by hemodynamic disturbances. An ideal small-diameter vascular graft has become a major focus of research. Novel biomaterials have been manufactured, and tissue-biomaterial interactions have been optimized. Tissue engineering technology has proven that the concept of partially or totally living blood vessels is feasible. The purpose of this review is to outline the vascular graft materials that are currently being implanted, taking into account cell-biomaterial physiology, tissue engineering approaches and the collective achievements of the authors.
References provided by Crossref.org
Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts